Selection of an Escherichia coli host that expresses mutant forms of Mycobacterium tuberculosis 2-trans enoyl-ACP(CoA) reductase and 3-ketoacyl-ACP(CoA) reductase enzymes

Protein Expression and Purification

Volumn 34, Issue 1, 2004, Pages 118-125

  Poletto, Simone S ^a   Da Fonseca, Isabel O ^a   De Carvalho, Luiz P S ^a   Basso, Luiz A ^a   Santos, Diógenes S ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Escherichia coli; Host selection; Mycobacteria; Protein expression

Indexed keywords

CORYNEBACTERINEAE; ESCHERICHIA COLI; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 1442289348     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2003.10.009     Document Type: Article

References (37)

1. M.C. Raviglione, The TB epidemic from 1992 to 2002, Tuberculosis 83 (2003) 4-14.
2. B.R. Bloom, C.J.L. Murray, Tuberculosis: commentary on a reemergent killer, Science 257 (1992) 1055-1064.
3. L.A. Basso, J.S. Blanchard, Resistance to antitubercular drugs, Adv. Exp. Med. Biol. 456 (1998) 115-144.
4. A. Plabos-Méndez, D.K. Gowda, T.R. Frieden, Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework, Bull. World Health Org. 80 (2002) 489-495.
5. R.J. O'Brien, P.P. Nunn, The need for new drugs against tuberculosis, Am. J. Respir. Crit. Care Med. 162 (2001) 1055-1958.
6. S.T. Cole, R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S.V. Gordon, K. Eiglmeier, S. Gas, C.E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh, J. McLean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M.A. Quail, M.A. Rajandream, J. Rogers, S. Rutter, K. Seeger, J. Skelton, S. Squares, R. Squares, J.E. Sulston, K. Taylor, S. Whitehead, B.G. Barrell, B.G. Deciphering, Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence, Nature 393 (1998) 537-544.
7. M.S. Glickman, W.R. Jacobs Jr., Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline, Cell 104 (2001) 477-485.
8. T.M. Shinnick, C.H. King, F.D. Quinn, Molecular biology, virulence, and pathogenicity of mycobacteria, Am. J. Med. Sci. 309 (1995) 92-98.
9. F. Baneyx, Recombinant protein expression in Escherichia coli, Curr. Opin. Biotechnol. 10 (1999) 411-421.
10. F.W. Studier, B.A. Moffat, Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes, J. Mol. Biol. 189 (1986) 113-130.
11. A. Quémard, J.C. Sacchettini, A. Dessen, C. Vilchèze, R. Bittman, W.R. Jacobs Jr., J.S. Blanchard, Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis, Biochemistry 34 (1995) 8235-8241.
12. L.A. Basso, D.S. Santos, W. Shi, R.H. Furneaux, P.C. Tyler, V.L. Schramm, J.S. Blanchard, Purine nucleoside phosphorylase from Mycobacterium tuberculosis analysis of inhibition by a transition-state analogue and dissection by parts, Biochemistry 28 (2001) 8196-8203.
13. J.S. Oliveira, C.A. Pinto, L.A. Basso, D.S. Santos, Cloning and overexpression in soluble form of functional shikimate kinase and 5-enolpyruvylshikimate 3-phosphate synthase enzymes from Mycobacterium tuberculosis, Protein Express. Purif. 3 (2001) 430-435.
14. W. Shi, L.A. Basso, D.S. Santos, P.C. Tyler, R.H. Furneaux, J.S. Blanchard, S.C. Almo, V.L. Schramm, Structures of purine nucleoside phosphorylase from Mycobacterium tuberculosis in complex with immucillin-H and its pieces, Biochemistry 28 (2001) 8204-8215.
15. L. Kremer, K.M. Nampoothiri, S. Lesjean, L.G. Dover, S. Graham, J. Betts, P.J. Brennan, D.E. Minnikin, C. Locht, G.S. Besra, Biochemical characterization of acyl carrier protein (AcpM) and malonyl-CoA:AcpM transacylase (mtFabD), two major components of Mycobacterium tuberculosis fatty acid synthase, J. Biol. Chem. 276 (2001) 27967-27974.
16. B. Miroux, J.E. Walker, Over-production of proteins in Escherichia coli: mutant host that allow synthesis of some membrane proteins and globular proteins at high levels, J. Mol. Biol. 260 (1996) 289-298.
17. R. Vicentelli, C. Bignon, A. Gruez, S. Canaan, G. Sulzenbacher, M. Tegoni, V. Campanacci, C. Cambillau, Medium-scale structural genomics: strategies for protein expression and crystallization, Acc. Chem. Res. 36 (2003) 165-172.
18. E.K. Schroeder, O.N. de Souza, D.S. Santos, J.S. Blanchard, L.A. Basso, Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis, Curr. Pharm. Biotechnol. 3 (2002) 197-225.
19. A. Banerjee, E. Dubnau, A. Quémard, V. Balasubramanian, K.S. Um, T. Wilson, D. Collins, G. Lisle, W.R. Jacobs Jr., inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis, Science 263 (1994) 227-230.
20. A. Banerjee, M. Sugantino, J.C. Sacchettini, W.R. Jacobs Jr., The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance, Microbiology 144 (1998) 2697-2704.
21. P.J. Brennan, Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis, Tuberculosis 83 (2003) 91-97.
22. + and a C16 fatty acyl substrate, J. Biol. Chem. 274 (1999) 15582-15589.
23. S. Parikh, D.P. Moynihan, G. Xiao, P.J. Tonge, Roles of tyrosine 158 and lysine 165 in the catalytic mechanism of InhA, the enoyl-ACP reductase from Mycobacterium tuberculosis, Biochemistry 38 (1999) 13623-13634.
24. B. Persson, Y. Kallberg, U. Oppermann, H. Jörnvall, Coenzyme-based functional assignments of short-chain dehydrogenases/reductases (SDRs) family, Chem. Biol. Interact. 143-144 (2003) 271-278.
25. J. Shanklin, Overexpression and purification of the Escherichia coli inner membrane enzyme acyl acyl carrier protein synthase in an active form, Protein Express. Purif. 18 (2000) 355-360.
26. S.N. Ho, H.D. Hunt, R.M. Horton, J.K. Pullen, L.R. Pease, Site directed mutagenesis by overlap extension using the polymerase chain reaction, Gene 77 (1989) 51-59.
27. M.A. Hayat, Basic Electron Microscopy Techniques, Nostrand Press, New York, 1972.
28. M.A. Hayat, Basic Techniques for Transmission Electron Microscopy, Academic Press, Orlando, 1986.
29. R.C. Austin, D. Singh, P.C.Y. Liaw, H.J. Craig, Visual detection method for identifying recombinant bacterial colonies, Bio.Techniques 18 (1995) 380-384.
30. S. Barik, Relationship between opacity of transformed E. coli colonies and over-expression of the recombinant transcript, BioTechniques 22 (1997) 112-118.
31. H. Dong, L. Nilsson, C.G. Kurland, Gratuitous overexpression of genes in Escherichia coli leads to growth, inhibition and ribosome destruction, J. Bacteriol. 177 (1995) 1497-1504.
32. T.H. Grossman, E.S. Kawasaki, S.P. Punreddy, M.S. Osburne, Spontaneous cAMP-dependent derepression of gene expression in stationary phase plays a role in recombinant expression instability, Gene 209 (1998) 95-103.
33. K.C. Kelley, K.J. Huestis, D.A. Austen, C.T. Sanderson, M.A. Donoghue, S.K. Stickel, E.S. Kawasaki, M.S. Osburne, Regulation of sCD4-183 gene expression from phage-T7-based vectors in Escherichia coli, Gene 156 (1995) 33-36.
34. W.R.A. Taylor, A 'periodic table' for protein structures, Nature 415 (2002) 657-660.
35. S.A. Lesley, P. Kuhn, A. Godzik, A.M. Deacon, I. Mathews, A. Kreusch, G. Spraggon, H.E. Klock, D. McMullan, T. Shin, J. Vincent, A. Robb, L.S. Brinen, M.D. Miller, T.M. McPhillips, M.A. Miller, D. Scheibe, J.M. Canaves, C. Guda, L. Jaroszewski, T.L. Selby, M.A. Elsliger, J. Wooley, S.S. Taylor, K.O. Hodgson, I.A. Wilson, P.G. Schultz, R.C. Stevens, Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipeline, Proc. Natl. Acad. Sci. USA 99 (2002) 11664-11669.
36. G. Hannig, S.C. Makrides, Strategies for optimizing heterologous protein expression in E. coli, Trends Biotechnol. 16 (1998) 54-60.
37. S.C. Makrides, Strategies for achieving high-level expression of genes in Escherichia coli, Microbiol. Rev. 60 (1996) 512-538.